BackgroundNovel bone substitutes have challenged the notion of autologous bone grafting as the ‘gold standard’ for the surgical treatment of fracture nonunions. The present study was designed to test the hypothesis that autologous bone grafting is equivalent to other bone grafting modalities in the management of fracture nonunions of the long bones.MethodsA retrospective review of patients with fracture nonunions included in two prospective databases was performed at two US level 1 trauma centers from January 1, 1998 (center 1) or January 1, 2004 (center 2), respectively, until December 31, 2010 (n = 574). Of these, 182 patients required adjunctive bone grafting and were stratified into the following cohorts: autograft (n = 105), allograft (n = 38), allograft and autograft combined (n = 16), and recombinant human bone morphogenetic protein-2 (rhBMP-2) with or without adjunctive bone grafting (n = 23). The primary outcome parameter was time to union. Secondary outcome parameters consisted of complication rates and the rate of revision procedures and revision bone grafting.ResultsThe autograft cohort had a statistically significant shorter time to union (198 ± 172–225 days) compared to allograft (416 ± 290–543 days) and exhibited a trend towards earlier union when compared to allograft/autograft combined (389 ± 159–619 days) or rhBMP-2 (217 ± 158–277 days). Furthermore, the autograft cohort had the lowest rate of surgical revisions (17%) and revision bone grafting (9%), compared to allograft (47% and 32%), allograft/autograft combined (25% and 31%), or rhBMP-2 (27% and 17%). The overall new-onset postoperative infection rate was significantly lower in the autograft group (12.4%), compared to the allograft cohort (26.3%) (P < 0.05).ConclusionAutologous bone grafting appears to represent the bone grafting modality of choice with regard to safety and efficiency in the surgical management of long bone fracture nonunions.
The Clouded leopard (Neofelis nebulosa) is a medium-sized highly arboreal cat. This study compares the structure of the digital, metacarpal and metatarsal pads of the manus and pes in N. nebulosa to that of the domestic cat (Felis catus). Covered by a stratified squamous cornified epithelium, the pads have a supple deposit of subepidermal fat that is partitioned by collagen fibers and extensively anchored to the muscle tendon sheaths. In both animals, a pes metatarsal pad suspensory ligament originates from the Mm. flexores digitorum profundi tendon and forms 3-4 small branches that project through the dermal fat layer and attach to the pad epidermis. In the cat manus, four tendons of equal size extend from the M. flexor digitorum superficialis (FDS) to form the manica flexoria in digits 2-4 from which extends a metacarpal pad suspensory ligament (MPSL) on digits 2 and 5 that extends into the tela subcutanea and epidermis. On digits 3 and 4 MPSL extends directly from the FDS tendon itself. In contrast, manus FDS tendons 1 and 5 in N. nebulosa were thin and either project directly to the tela subcutanea (tendon 1) or connect with the manica flexoria forming a metacarpal pad suspensory ligament (tendon 5). Tendons 2-4 connect with the manica flexoria from which MPSL project into the tela subcutanea and epidermis. In both species, the suspensory ligaments may serve to contract the pad to conform to the under lying substrate, thus enhancing the animal's ability to grip branches while climbing.
Staphylococcus aureus nasal colonization in trauma patients with open fractures is similar to that of the general community. In this pilot study, the addition of vancomycin to standard antibiotic prophylaxis was found safe, but its efficacy should be evaluated in a larger multiinstitutional trial.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.